Terms: = Prostate cancer AND AFP, AFPD, FETA, HPAFP AND Diagnosis
44 results:
1. Relevance of blood tumor markers in inpatients with significant involuntary weight loss and elevated levels of inflammation biomarkers.
Gronnier M; Hedhli K; Sauzay C; Salle V; Duhaut P; Schmidt J; Dernoncourt A
BMC Cancer; 2024 Apr; 24(1):468. PubMed ID: 38622530
[TBL] [Abstract] [Full Text] [Related]
2. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
[TBL] [Abstract] [Full Text] [Related]
3. Early-stage hepatocellular carcinoma screening in patients with chronic hepatitis B in China: a cost-effectiveness analysis.
Nan Y; Garay OU; Lu X; Zhang Y; Xie L; Niu Z; Chen W
J Comp Eff Res; 2024 Apr; 13(4):e230146. PubMed ID: 38415341
[No Abstract] [Full Text] [Related]
4. Tumour Marker Requisition Pattern in a Tertiary Care Centre of Eastern Nepal.
Niraula A; Gelal B; Chaudhari RK; Das BK; Lamsal M
Kathmandu Univ Med J (KUMJ); 2022; 20(80):422-426. PubMed ID: 37795716
[TBL] [Abstract] [Full Text] [Related]
5. The Impact of a History of Different Other cancers on the Long-Term Outcomes of Patients with Intrahepatic Cholangiocarcinoma: A Population-Based Analysis.
Chai J; Kong J; Zhu K
Biomed Res Int; 2022; 2022():3970884. PubMed ID: 35257009
[TBL] [Abstract] [Full Text] [Related]
6. Tumor-Specificity Growth Factor Combined with Tumor Markers in Nuclear Medicine Imaging to Identify prostate cancer Osteonosus.
Zhang X; Chen Z
J Healthc Eng; 2021; 2021():7380120. PubMed ID: 34925738
[TBL] [Abstract] [Full Text] [Related]
7. Lectin Affinity Chromatography for the Discovery of Novel cancer Glycobiomarkers: A Case Study with PSA Glycoforms and prostate cancer.
Llop E; Peracaula R
Methods Mol Biol; 2022; 2370():301-313. PubMed ID: 34611876
[TBL] [Abstract] [Full Text] [Related]
8. Somatic-Type Yolk Sac Tumor Arising as a Predominant Component of Bladder Urothelial Carcinoma.
Collins K; Alkashash AM; Hwang M; Kaimakliotis HZ; Cheng L; Idrees MT
Int J Surg Pathol; 2022 Apr; 30(2):207-213. PubMed ID: 34255554
[TBL] [Abstract] [Full Text] [Related]
9. [Pathological features of primary extragonadal germ cell tumor of the prostate with small round blue cell morphology].
Gan HL; Wang QF
Zhonghua Bing Li Xue Za Zhi; 2021 Feb; 50(2):108-113. PubMed ID: 33535304
[No Abstract] [Full Text] [Related]
10. Tumour markers and their utility in imaging of abdominal and pelvic malignancies.
Lahoud RM; O'Shea A; El-Mouhayyar C; Atre ID; Eurboonyanun K; Harisinghani M
Clin Radiol; 2021 Feb; 76(2):99-107. PubMed ID: 32861463
[TBL] [Abstract] [Full Text] [Related]
11. Simultaneous Detection of Multiple Tumor Markers in Blood by Functional Liquid Crystal Sensors Assisted with Target-Induced Dissociation of Aptamer.
Qi L; Liu S; Jiang Y; Lin JM; Yu L; Hu Q
Anal Chem; 2020 Mar; 92(5):3867-3873. PubMed ID: 32069024
[TBL] [Abstract] [Full Text] [Related]
12. Dual-Aptamer Modified Graphene Field-Effect Transistor Nanosensor for Label-Free and Specific Detection of Hepatocellular Carcinoma-Derived Microvesicles.
Wu D; Yu Y; Jin D; Xiao MM; Zhang ZY; Zhang GJ
Anal Chem; 2020 Mar; 92(5):4006-4015. PubMed ID: 32040907
[TBL] [Abstract] [Full Text] [Related]
13. Nanoparticle-aided glycovariant assays to bridge biomarker performance and ctDNA results.
Gidwani K; Kekki H; Terävä J; Soukka T; Sundfeldt K; Pettersson K
Mol Aspects Med; 2020 Apr; 72():100831. PubMed ID: 31787337
[TBL] [Abstract] [Full Text] [Related]
14. Circulating long non-coding RNA PCGEM1 as a novel biomarker for gastric cancer diagnosis.
Jiang H; Guo S; Zhao Y; Wang Y; Piao HY; Wu Y; Zhang J
Pathol Res Pract; 2019 Oct; 215(10):152569. PubMed ID: 31421977
[TBL] [Abstract] [Full Text] [Related]
15. Vertical flow assays based on core-shell SERS nanotags for multiplex prostate cancer biomarker detection.
Chen R; Liu B; Ni H; Chang N; Luan C; Ge Q; Dong J; Zhao X
Analyst; 2019 Jul; 144(13):4051-4059. PubMed ID: 31157328
[TBL] [Abstract] [Full Text] [Related]
16. Rolling circle amplification integrated with suspension bead array for ultrasensitive multiplex immunodetection of tumor markers.
Gao M; Lian H; Yu L; Gong M; Ma L; Zhou Y; Yu M; Yan X
Anal Chim Acta; 2019 Feb; 1048():75-84. PubMed ID: 30598160
[TBL] [Abstract] [Full Text] [Related]
17. Multiplex measurement of twelve tumor markers using a GMR multi-biomarker immunoassay biosensor.
Gao Y; Huo W; Zhang L; Lian J; Tao W; Song C; Tang J; Shi S; Gao Y
Biosens Bioelectron; 2019 Jan; 123():204-210. PubMed ID: 30174274
[TBL] [Abstract] [Full Text] [Related]
18. Identification and characterization of monoclonal antibodies against GP73 for use as a potential biomarker in liver cancer screening and diagnosis.
Zhang Y; Xi Y; Fang J; Luo S; Wilson JJ; Huang RP
J Immunoassay Immunochem; 2016; 37(4):390-406. PubMed ID: 27088654
[TBL] [Abstract] [Full Text] [Related]
19. A nanoplasmonic biosensor for label-free multiplex detection of cancer biomarkers.
Lee JU; Nguyen AH; Sim SJ
Biosens Bioelectron; 2015 Dec; 74():341-6. PubMed ID: 26159154
[TBL] [Abstract] [Full Text] [Related]
20. Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.
Yu M; Wang YH; Abdalla AME; Liu WQ; Mei F; Wang J; Ouyang CX; Li YQ
J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):722-728. PubMed ID: 25318883
[TBL] [Abstract] [Full Text] [Related]
[Next]
